Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by TommyNickelson Oct 23, 2024 1:30pm

234 Views

Post# 36278863

FDA recommendation

Odds greater than 50% the FDA has given its recommendation already.

If full go-ahead, I would imagine next PR is the formal filing. Surely the paperwork is complete and ready to submit.

If partial go-ahead and filing soon but not after some tweaking done, I would think a PR stating this. "BTD expected to be filed in November."

If another roadblock, will be silence.

I think it's 50 / 50 for options 1 and 2. Option 3 doesn't jive with IR's email blast.

<< Previous

Bullboard Posts

Next >>

Beware of October's stock market scares